Aclaris Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
/ 
Frequently asked questions
To buy Aclaris Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aclaris Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aclaris Therapeutics Inc. is ACRS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aclaris Therapeutics Inc. has its primary listing on NASDAQ. You can trade Aclaris Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aclaris Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aclaris Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aclaris Therapeutics Inc. or others.